BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 35664229)

  • 1. Gut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives.
    Li M; Yang L; Mu C; Sun Y; Gu Y; Chen D; Liu T; Cao H
    Comput Struct Biotechnol J; 2022; 20():2402-2414. PubMed ID: 35664229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease.
    Weng YJ; Gan HY; Li X; Huang Y; Li ZC; Deng HM; Chen SZ; Zhou Y; Wang LS; Han YP; Tan YF; Song YJ; Du ZM; Liu YY; Wang Y; Qin N; Bai Y; Yang RF; Bi YJ; Zhi FC
    J Dig Dis; 2019 Sep; 20(9):447-459. PubMed ID: 31240835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Disease-Associated Microbial and Metabolomics State in Relatives of Pediatric Inflammatory Bowel Disease Patients.
    Jacobs JP; Goudarzi M; Singh N; Tong M; McHardy IH; Ruegger P; Asadourian M; Moon BH; Ayson A; Borneman J; McGovern DP; Fornace AJ; Braun J; Dubinsky M
    Cell Mol Gastroenterol Hepatol; 2016 Nov; 2(6):750-766. PubMed ID: 28174747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiome, metabolome, host immunity associated with inflammatory bowel disease and intervention of fecal microbiota transplantation.
    Wu R; Xiong R; Li Y; Chen J; Yan R
    J Autoimmun; 2023 Dec; 141():103062. PubMed ID: 37246133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotic Cocktail Alleviates Intestinal Inflammation Through Improving Gut Microbiota and Metabolites in Colitis Mice.
    Zhu Y; Xu Y; Wang X; Rao L; Yan X; Gao R; Shen T; Zhou Y; Kong C; Zhou L
    Front Cell Infect Microbiol; 2022; 12():886061. PubMed ID: 35782138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qingchang Huashi Formula attenuates DSS-induced colitis in mice by restoring gut microbiota-metabolism homeostasis and goblet cell function.
    Hu J; Huang H; Che Y; Ding C; Zhang L; Wang Y; Hao H; Shen H; Cao L
    J Ethnopharmacol; 2021 Feb; 266():113394. PubMed ID: 32941971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary metabolic insights into host-gut microbial interactions in healthy and IBD children.
    Martin FP; Su MM; Xie GX; Guiraud SP; Kussmann M; Godin JP; Jia W; Nydegger A
    World J Gastroenterol; 2017 May; 23(20):3643-3654. PubMed ID: 28611517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis.
    Yang Y; Zheng X; Wang Y; Tan X; Zou H; Feng S; Zhang H; Zhang Z; He J; Cui B; Zhang X; Wu Z; Dong M; Cheng W; Tao S; Wei H
    Front Immunol; 2022; 13():836542. PubMed ID: 35237276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent Fasting Alleviates Risk Markers in a Murine Model of Ulcerative Colitis by Modulating the Gut Microbiome and Metabolome.
    Wu J; Man D; Shi D; Wu W; Wang S; Wang K; Li Y; Yang L; Bian X; Wang Q; Li L
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon.
    Ward JBJ; Lajczak NK; Kelly OB; O'Dwyer AM; Giddam AK; Ní Gabhann J; Franco P; Tambuwala MM; Jefferies CA; Keely S; Roda A; Keely SJ
    Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G550-G558. PubMed ID: 28360029
    [No Abstract]   [Full Text] [Related]  

  • 11. Gut microbiome structure and metabolic activity in inflammatory bowel disease.
    Franzosa EA; Sirota-Madi A; Avila-Pacheco J; Fornelos N; Haiser HJ; Reinker S; Vatanen T; Hall AB; Mallick H; McIver LJ; Sauk JS; Wilson RG; Stevens BW; Scott JM; Pierce K; Deik AA; Bullock K; Imhann F; Porter JA; Zhernakova A; Fu J; Weersma RK; Wijmenga C; Clish CB; Vlamakis H; Huttenhower C; Xavier RJ
    Nat Microbiol; 2019 Feb; 4(2):293-305. PubMed ID: 30531976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients.
    Alexander JL; Mullish BH; Danckert NP; Liu Z; Olbei ML; Saifuddin A; Torkizadeh M; Ibraheim H; Blanco JM; Roberts LA; Bewshea CM; Nice R; Lin S; Prabhudev H; Sands C; Horneffer-van der Sluis V; Lewis M; Sebastian S; Lees CW; Teare JP; Hart A; Goodhand JR; Kennedy NA; Korcsmaros T; Marchesi JR; Ahmad T; Powell N
    EBioMedicine; 2023 Feb; 88():104430. PubMed ID: 36634565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.
    Nagao-Kitamoto H; Shreiner AB; Gillilland MG; Kitamoto S; Ishii C; Hirayama A; Kuffa P; El-Zaatari M; Grasberger H; Seekatz AM; Higgins PD; Young VB; Fukuda S; Kao JY; Kamada N
    Cell Mol Gastroenterol Hepatol; 2016 Jul; 2(4):468-481. PubMed ID: 27795980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amelioration of Colitis by a Gut Bacterial Consortium Producing Anti-Inflammatory Secondary Bile Acids.
    Zhou C; Wang Y; Li C; Xie Z; Dai L
    Microbiol Spectr; 2023 Mar; 11(2):e0333022. PubMed ID: 36943054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered gut microbiome, bile acid composition and metabolome in sarcopenia in liver cirrhosis.
    Aliwa B; Horvath A; Traub J; Feldbacher N; Habisch H; Fauler G; Madl T; Stadlbauer V
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2676-2691. PubMed ID: 37767786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated multi-omics reveal gut microbiota-mediated bile acid metabolism alteration regulating immunotherapy responses to anti-α4β7-integrin in Crohn's disease.
    Han B; Tang D; Lv X; Fan J; Li S; Zhu H; Zhang J; Xu S; Xu X; Huang Z; Huang Z; Lin G; Zhan L; Lv X
    Gut Microbes; 2024; 16(1):2310894. PubMed ID: 38312103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metagenomic and bile acid metabolomic analysis of fecal microbiota transplantation for recurrent Clostridiodes difficile and/or inflammatory bowel diseases.
    Ramos RJ; Zhu C; Joseph DF; Thaker S; Lacomb JF; Markarian K; Lee HJ; Petrov JC; Monzur F; Buscaglia JM; Chawla A; Small-Harary L; Gathungu G; Morganstern JA; Yang J; Li J; Pamer EG; Robertson CE; Frank DN; Cross JR; Li E
    Med Res Arch; 2022 Oct; 10(10):. PubMed ID: 36618438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases.
    Hosseinkhani F; Heinken A; Thiele I; Lindenburg PW; Harms AC; Hankemeier T
    Gut Microbes; 2021; 13(1):1-22. PubMed ID: 33590776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disturbances of the Gut Microbiota and Microbiota-Derived Metabolites in Inflammatory Bowel Disease.
    Hu Y; Chen Z; Xu C; Kan S; Chen D
    Nutrients; 2022 Dec; 14(23):. PubMed ID: 36501169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faecal microbiota transplantation: looking beyond clostridium difficile infection at inflammatory bowel disease.
    Patel K; Patel A; Hawes D; Shah J; Shah K
    Gastroenterol Hepatol Bed Bench; 2018; 11(1):1-8. PubMed ID: 29564058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.